Business Wire | Oct 29, 2021 04:30PM EDT

ANI Pharmaceuticals to Discuss Third Quarter 2021 Financial Results on November 1, 2021

Oct. 29, 2021

BAUDETTE, Minn.--(BUSINESS WIRE)--Oct. 29, 2021--ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (NASDAQ: ANIP) today announced that the Company will release its third quarter 2021 financial results on Monday, November 1, 2021.

Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:

Date Monday, November 1, 2021

Time 8:30 a.m. ET

Toll free (U.S.) 877-876-9173

Webcast (live and www.anipharmaceuticals.com, under the "Investors"replay) section

A replay of the conference call will be available within two hours of the call's completion and will remain accessible for one-week by dialing 800-938-2243 and entering access code 6513021.

About ANI

ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211029005532/en/

CONTACT: Investor Relations: Lisa M. Wilson, In-Site Communications, Inc. T: 212-452-2793 E: lwilson@insitecony.com